The 2018 China Supply Chain Executive Summit (CSCES 2018), organized by Conways Asia, will be held in Beijing, China during June 21-12, 2018 and supported by influential and authoritative associations, media and governments. And now after yearly and successfully held, the CSCES series summits have already been the landmark for supply chain area in Asia.
CSCES as the most influential supply chain gala with a global perspective, in-depth discussion of the domestic and international supply chain trends and issues. More than 500 supply chain, logistic, Channel heads from industries like FMCG, electronics, E-commerce, Internet, artificial intelligence, big data, aerospace, etc. will gather for the superb opportunity for conversation, collaboration, and networking.
Group President Assistant and General Manager of Omni-Channel Center
Senior Director in Supply Chain Division
Supply Chain Professional & Head of End-to-End Supply Network Design
GM of Supply Chain Manufacturing Products
Director , Retail Fulfillment Operation
Supply Chain Finance Director
Head of Nokia Manufacturing and Delivery Procurement & SNE Transformation Officer
Head of China's Demand and Supply Chain Management
Beijing Capital Agribusiness Group (CAG)
GM of Logistics
Mr. Alex Liu received his M.S. degree in molecular pharmacology from Peking Union Medical Collage and an LLM degree in IP Law from Franklin Pierce Law School (US). Mr. Liu is qualified both as a patent attorney in China and a patent agent in the US. As an experienced patent practitioner working in a multi-national company in China, Mr. Liu is adept at developing IP strategies and managing IP portfolios that position businesses to take advantage of both legal and business opportunities. As part of his previous practice as an external counsel, Mr. Liu provided expert advice on issues including patentability, validity, infringement, freedom-to-operate, due diligence, etc. After joining Bayer China since 2007, Mr. Liu also helped his company draft and negotiate technology transfer agreements, IP licensing agreements, and other contracts related to IP transaction in the areas of pharmaceuticals, agrichemicals, biotechnology, and medical devices. As now being the IP Head of Bayer China since 2013, he is conducting/coordinating all types of IP issues for the company in the APEC region.